Impact of RT-PCR monitoring on the long-term survival in acute promyelocytic leukemia

Chinese Medical Journal

Volumn 113, Issue 10, 2000, Pages 899-902

  Hu, Jiong ^a   Yu, Ting ^a   Zhao, Weili ^a   Gu, Bowei ^a   Shen, Zhixiang ^a   Li, Xiusong ^a   Sun, Guanlin ^a   Chen, Saijuan ^a   Wang, Zhenyi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute promyelocytic leukemia; Minimal residual disease; RT PCR

Indexed keywords

ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA-RETINOIC ACID RECEPTOR ALPHA FUSION ONCOPROTEIN; TUMOR PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; GENETICS; HUMAN; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; PROMYELOCYTIC LEUKEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVOR;

ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVORS;

EID: 0041083267     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Lo Coco F, Nervi C, Avvisati G, et al. Acute promyelocytic leukemia: a curable disease. Leukemia 1998;12:1866-1880.
2. Huang W, Sun GL, Li XS, et al. Acute promyelocytic leukemia: clinical relevance of two major PML/RARα isoform and detection of minimal residual disease by retro-transcriptase polymerase chain reaction to predict relapse. Blood 1993;82:1264-1269.
3. Biondi A, Rambaldi A, Pandolfi PP, et al. Molecular monitoring of the MYL/RARα fusion gene in acute promyelocytic leukemia by polymerase chain reaction. Blood 1992;80:492-497.
4. Burnett AK, Grimwade D, Solomon E, et al. Presenting WBC and kinetics of molecular remission predict prognosis in acute promyelocyte leukemia treated with ATRA: results of the randomized MRC trial. Blood 1999;93:4131-4143.
5. Lo Coco F, Diverio D, Pandolfi PP, et al. Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukemia. Lancet 1998;340:1437-1438.
6. Asou N, Adachi K, Tamura J, et al. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. J Clin Oncol 1998;16:78-85.
7. Diverio D, Rossi V, Avvisati G, et al. Early detection of relapse by prospective retro-transcriptase polymerase chain reaction of PML/RARα fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP multicenter "AIDA" trial. Blood 1998;92:784-789.
8. Mandelli F, Daniela D, Avvisati G, et al. Molecular remission in PML-RARα positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin(AIDA) therapy. Blood 1997;90: 1014-1021.